Deep learning-enabled point-of-care sensing using multiplexed paper-based sensors

Deep learning-enabled point-of-care sensing using multiplexed paper-based sensors

Deep learning-enabled point-of-care sensing using multiplexed paper-based sensors

Hyouarm Joung et al.
Hyouarm Joung et al.
May 7, 2020
May 7, 2020

Significance of the Science

Heart disease remains the leading cause of death worldwide, and predicting cardiovascular risk often relies on measuring C-reactive protein (CRP), a blood marker of inflammation. Current high-sensitivity CRP (hsCRP) tests require expensive laboratory instruments, making them inaccessible in many settings. Paper-based tests are simpler and cheaper but typically lack the precision needed for reliable CRP measurement. This study bridges that gap by combining paper-based sensors with deep learning algorithms, creating a portable, low-cost system capable of high-quality hsCRP testing at the point of care.

Highlights

  • Developed a paper-based vertical flow test and a smartphone-based reader for high-sensitivity CRP, a key heart health biomarker

  • Combined the test with deep learning to interpret results more accurately

  • Achieved 11.2% variation and 0.95 linearity in a blind test of 85 human samples, compared to results of FDA-approved assay

  • Delivered results in under 12 minutes at a cost of less than $0.50 per test

Summary

This study presents a computationally enhanced paper-based vertical flow assay (VFA) for high-sensitivity C-reactive protein (hsCRP) testing, used to assess cardiovascular disease risk. By integrating deep learning with a multiplexed immunoreaction membrane, the system was trained to identify the most reliable sensing spots and accurately infer CRP concentrations. In a blind clinical study of 85 patient serum samples, the test achieved a coefficient of determination (R²) of 0.95 compared with an FDA-approved reference assay, with an average coefficient of variation of 11.2%. The method also successfully avoided false readings caused by the hook effect, extending the dynamic range of detection. With results delivered in under 12 minutes and a materials cost below $0.50, this approach demonstrates how machine learning and low-cost paper diagnostics can be combined to create portable, accurate, and affordable point-of-care tests for cardiovascular risk assessment.

Read more (open access): https://www.nature.com/articles/s41746-020-0274-y

Significance of the Science

Heart disease remains the leading cause of death worldwide, and predicting cardiovascular risk often relies on measuring C-reactive protein (CRP), a blood marker of inflammation. Current high-sensitivity CRP (hsCRP) tests require expensive laboratory instruments, making them inaccessible in many settings. Paper-based tests are simpler and cheaper but typically lack the precision needed for reliable CRP measurement. This study bridges that gap by combining paper-based sensors with deep learning algorithms, creating a portable, low-cost system capable of high-quality hsCRP testing at the point of care.

Highlights

  • Developed a paper-based vertical flow test and a smartphone-based reader for high-sensitivity CRP, a key heart health biomarker

  • Combined the test with deep learning to interpret results more accurately

  • Achieved 11.2% variation and 0.95 linearity in a blind test of 85 human samples, compared to results of FDA-approved assay

  • Delivered results in under 12 minutes at a cost of less than $0.50 per test

Summary

This study presents a computationally enhanced paper-based vertical flow assay (VFA) for high-sensitivity C-reactive protein (hsCRP) testing, used to assess cardiovascular disease risk. By integrating deep learning with a multiplexed immunoreaction membrane, the system was trained to identify the most reliable sensing spots and accurately infer CRP concentrations. In a blind clinical study of 85 patient serum samples, the test achieved a coefficient of determination (R²) of 0.95 compared with an FDA-approved reference assay, with an average coefficient of variation of 11.2%. The method also successfully avoided false readings caused by the hook effect, extending the dynamic range of detection. With results delivered in under 12 minutes and a materials cost below $0.50, this approach demonstrates how machine learning and low-cost paper diagnostics can be combined to create portable, accurate, and affordable point-of-care tests for cardiovascular risk assessment.

Read more (open access): https://www.nature.com/articles/s41746-020-0274-y

The Kompass system is in development and is not available for in vitro diagnostic use. 

© 2025 Kompass Diagnostics.

The Kompass system is in development and is not available for in vitro diagnostic use. 

© 2025 Kompass Diagnostics.

The Kompass system is in development and is not available for in vitro diagnostic use. 

© 2025 Kompass Diagnostics.

The Kompass system is in development and is not available for in vitro diagnostic use. 

© 2025 Kompass Diagnostics.